Epstein Secrets

now called Adverum Biotechnologles 4/20/15 10,000 298.806 28,500 25,500 -373,106 BASF ADR 4/13/15 5000 508,056 486,430 472,250 -35.806 Bank of New York Mellon 6/25/14 250,000 9.076,406 11,765,000 11,780.000 2,703.594 Biogen Idec Inc 2/14/12 2,095 250,455 568,185 519,078 268,623 Bioverativ Inc

eral Motors Co 12/9/10 97,525 3,585.947 3,378,266 3,309,023 -276,924 General Electric Co 4/23/13 23,000 496,109 666,777 629,740 133.631 Gilead Sciences Inc 215/14 5,000 396.407 342,760 324,450 -71.957 Gilead Sciences Inc 3/7/14 3,100 246,797 212,505 201,159 -45,638 Glaxo Smith Me PLC 6/10/

now called Adverum Blotechnologles 4/20/15 10,000 398,606 25 030 25500 -373.106 BASF ADR 4/13/15 5,000 508,056 466,450 476.350 -31,708 Bank of New York Mellon 6/25/14 250,000 12,755,000 0 Biogen Idec Inc 2114/12 2,095 250,455 568,499 606.691 356,236 Bioverativ Inc 2/1/17 1,047 20,254 62,998

1.265,037 1,980,743 1.761.491 496,454 General Motors Co 12/9110 97 525 3.406.548 - 0 General Electric Co 4123113 23:540 621.230 - 0 Gilead Sciences Inc 2/5/14 5,000 396,407 353,900 380,450 -15957 -1O18 Gilead Sciences Inc 3/7/14 3,100 246,797 219.418 235579 Glaxo Smith Kline PLC 6/10/1

les now called Adverum Beledinolcoes 4120115 10000 398,606 25,000 25500 -373,108. BASF ADR 4/13/15 ‘000 508,056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250,000 9,076 406 12,755,000 - -9,076 408 Biogen Idec Inc 2/14/12 Z095 250,455 568,499 608.691 356,236 Bioverativ Inc 2/1/17

496,454 General Motors Co 12/9/10 97,525 3,585,947 3,406,548 - -3585 947; General Electric Co 4/23/13 23,000 496.109 621,230 -496.10M Gilead Sciences Inc Gilead Sciences Inc 2/5/14 5,000 396 407 353,900 380 450 -15 957 57)14 3,100 246,797 --- 1i9,418 235,879 -10,918! Glaxo Smith Kline PLC

s now called Advorum Btotochnolowes 4/20/16 10,000 398,606 25,000 25,500 373,106 BASF ADR 4/13/15 5,000 508.056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250.000 9.076.406 12,755,000 -9,076,406 356.236 Biogen Idec Inc 2114/12 2,095 250,455 568,499 606.691 Bioverativ Inc OM 1,047

1,491 496,454 General Motors Co 12/9/10 97,525 3.585,947 3406548 -3,565,947 General Electric Co 4/23/13 23,000 496,109 621,230 -496,109 Gilead Sciences Inc 2/5/14 5,000 396,407 353 900 380 450 -15,957 Gilead Sciences Inc 3/7/14 3,100 246,797 219,418 235,879 202,600 -10.918 -12,406 'Cie xo

now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 250.455 568,499 606,691 356238 Bioverativ Inc 2/1/17 1,047 20,254 62,9

1,265,037 1,980,743 1,761,491 496,454 General Motors Co 12/9/10 97,525 3.406,548 - 0 General Electric Co 4/23/13 23,000 621,230 - 0 Gilead Sciences Inc 2/5/14 5,000 396,407 353.900 380,450 -15,957 Gilead Sciences Inc 3/7/14 3,100 246,797 219,418 235,679 -10.918 Glaxo Smith Kline PLC 6/

s now called Adverum Biotechnologies 4/20/15 10 000 398,606 25500 25,000 -373 606 -41,606 BASF ADR 4/13/15 5000 508,056 472,250 486,450 Bank of New York Mellon 6/25/14 2517,000 9,076,406 11,780,000 12,755,000 3,678594 318.044 Blogen Idec Inc 2/14/12 2,095 250.455 519.078 568,499 Bioverativ Inc

eral Motors Co 12/9/10 97,525 3,585,947 3,309,023 3,406,548 -179,399 General Electric Co 4/23/13 23,000 496,109 629,740 621.230 125.121 Gilead Sciences Inc 2/5/14 5,000 396,407 324,450 353,900 -42,507 Gilead Sciences Inc 3/7/14 3,100 246,797 201,159 219,418 -27,379 Glaxo Smith Kline PLC 6/

now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 250.455 568,499 606,691 356238 Bioverativ Inc 2/1/17 1,047 20,254 62,9

1,265,037 1,980,743 1,761,491 496,454 General Motors Co 12/9/10 97,525 3.406,548 - 0 General Electric Co 4/23/13 23,000 621,230 - 0 Gilead Sciences Inc 2/5/14 5,000 396,407 353.900 380,450 -15,957 Gilead Sciences Inc 3/7/14 3,100 246,797 219,418 235,679 -10.918 Glaxo Smith Kline PLC 6/

1,698,200 1,578,640 520,520 Apple Inc (53,820 shares were moved to margin account) 9/5/14 150,000 14,842,506 18,195,000 16,914,000 2,071,494 Bank of New York Mellon 6/25/14 250,000 9,076,406 10,850,000 9,950,000 873,594 Biogen Idec Inc 2/14/12 2,095 250,455 667,844 622,844 372,389 Facebook Inc 5/17/1

72,389 Facebook Inc 5/17/12 17,500 665,000 1,645,175 1,565,025 900,025 General Electric Co 4/23/13 23,000 496,109 600,300 570,860 74,751 Gilead Sciences Inc 2/5/14 5,000 396,407 589,300 525,350 128,943 Gilead Sciences Inc 3/7/14 3,100 246,797 365,366 325,717 78,920 GoDaddy Inc. 4/1/15 700 14,0

s now called Advorum Btotochnolowes 4/20/16 10,000 398,606 25,000 25,500 373,106 BASF ADR 4/13/15 5,000 508.056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250.000 9.076.406 12,755,000 -9,076,406 356.236 Biogen Idec Inc 2114/12 2,095 250,455 568,499 606.691 Bioverativ Inc OM 1,047

1,491 496,454 General Motors Co 12/9/10 97,525 3.585,947 3406548 -3,565,947 General Electric Co 4/23/13 23,000 496,109 621,230 -496,109 Gilead Sciences Inc 2/5/14 5,000 396,407 353 900 380 450 -15,957 Gilead Sciences Inc 3/7/14 3,100 246,797 219,418 235,879 202,600 -10.918 -12,406 'Cie xo